Staphylococcus aureus adapts to oxidative stress by producing H2O2-resistant small-colony variants via the SOS response

Infection and Immunity

Volumn 83, Issue 5, 2015, Pages 1830-1844

  Painter, Kimberley L ^a   Strange, Elizabeth ^a   Parkhill, Julian ^b   Bamford, Kathleen B ^c   Armstrong James, Darius ^a,d   Edwards, Andrew M ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

^c IMPERIAL COLLEGE HEALTHCARE NHS TRUST   (United Kingdom)

^d NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; ANTIBIOTIC AGENT; BACTERIAL PROTEIN; CATALASE; CHLORAMPHENICOL; DEOXYRIBONUCLEOPROTEIN; DNA POLYMERASE V; DOUBLE STRANDED DNA; ERYTHROMYCIN; FUSIDIC ACID; GENTAMICIN; HEME; HYDROGEN PEROXIDE; KANAMYCIN; PARAQUAT; RECOMBINASE A PROTEIN; REXAB PROTEIN; SULFONAMIDE; TETRACYCLINE; UNCLASSIFIED DRUG; DNA DIRECTED DNA POLYMERASE; RECOMBINASE;

ANTIBIOTIC RESISTANCE; ARTICLE; AUXOTROPHY; BACTERIAL MUTATION; BACTERIAL PHENOMENA AND FUNCTIONS; BACTERIAL STRAIN; BACTERIOSTASIS; BACTERIUM COLONY; CHRONOLOGY; COLONY FORMING UNIT; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DNA REPAIR; DOUBLE STRANDED DNA BREAK; ENZYME ACTIVITY; MICROBIAL DIVERSITY; MICROBIAL POPULATION DYNAMICS; MUTATION RATE; NONHUMAN; OXIDATIVE STRESS; PHENOTYPE; PRIORITY JOURNAL; REVERTANT; SMALL COLONY VARIANT; STAPHYLOCOCCUS AUREUS; WILD TYPE; ADAPTATION; DRUG EFFECTS; ENZYMOLOGY; GROWTH, DEVELOPMENT AND AGING; METABOLISM; PHYSIOLOGY;

ADAPTATION, BIOLOGICAL; CATALASE; DNA-DIRECTED DNA POLYMERASE; HYDROGEN PEROXIDE; OXIDATIVE STRESS; RECOMBINASES; SOS RESPONSE (GENETICS); STAPHYLOCOCCUS AUREUS;

EID: 84928181255     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.03016-14     Document Type: Article

References (86)

1. Abele-Horn M, Schupfner B, Emmerling P, Waldner H, Göring H. 2000. Persistent wound infection after herniotomy associated with smallcolony variants of Staphylococcus aureus. Infection 2:53-54. http://dx.doi.org/10.1007/s150100050014.
2. Acar JF, Goldstein FW, Lagrange P. 1978. Human infections caused by thiamine- or menadione-requiring Staphylococcus aureus. J Clin Microbiol 8:142-147.
3. Agarwal H, Verrall R, Singh SP, Tang YW, Wilson G. 2007. Small colony variant Staphylococcus aureus multiorgan infection. Pediatr Infect Dis J 26:269-271. http://dx.doi.org/10.1097/01.inf.0000256749.29244.67.
4. Besier S, Ludwig A, Ohlsen K, Brade V, Wichelhaus TA. 2007. Molecular analysis of the thymidine-auxotrophic small colony variant phenotype of Staphylococcus aureus. Int J Med Microbiol 297:217-225. http://dx.doi.org/10.1016/j.ijmm.2007.02.003.
5. Kahl B, Herrmann M, Everding AS, Koch HG, Becker K, Harms E, Proctor RA, Peters G. 1998. Persistent infection with small colony variant strains of Staphylococcus aureus in patients with cystic fibrosis. J Infect Dis 177:1023-1029. http://dx.doi.org/10.1086/515238.
6. Kahl BC. 2014. Small colony variants (SCVs) of Staphylococcus aureus: a bacterial survival strategy. Infect Genet Evol 21:515-522. http://dx.doi.org/10.1016/j.meegid.2013.05.016.
7. Kipp F, Ziebuhr W, Becker K, Krimmer V, Höbeta N, Peters G, Von Eiff C. 2003. Detection of Staphylococcus aureus by 16S rRNA directed in situ hybridization in a patient with a brain abscess caused by small colony variants. J Neurol Neurosurg Psychiatry 74:1000-1002. http://dx.doi.org/10.1136/jnnp.74.7.1000.
8. Proctor RA, van Langevelde P, Kristjansson M, Maslow JN, Arbeit RD. 1995. Persistent and relapsing infections associated with small-colony variants of Staphylococcus aureus. Clin Infect Dis 20:95-102. http://dx.doi.org/10.1093/clinids/20.1.95.
9. Proctor RA, von Eiff C, Kahl BC, Becker K, McNamara P, Herrmann M, Peters G. 2006. Small colony variants: a pathogenic form of bacteria that facilitates persistent and recurrent infections. Nat Rev Microbiol 4:295-305. http://dx.doi.org/10.1038/nrmicro1384.
10. Sendi P, Rohrbach M, Graber P, Frei R, Ochsner PE, Zimmerli W. 2006. Staphylococcus aureus small colony variants in prosthetic joint infection. Clin Infect Dis 43:961-967. http://dx.doi.org/10.1086/507633.
11. Seifert H, von Eiff C, Fätkenheuer G. 1999. Fatal case due to methicillin-resistant Staphylococcus aureus small colony variants in an AIDS patient. Emerg Infect Dis 5:450-453. http://dx.doi.org/10.3201/eid0503.990319.
12. Tuchscherr L, Medina E, Hussain M, Völker W, Heitmann V, Niemann S, Holzinger D, Roth J, Proctor RA, Becker K, Peters G, Löffler B. 2011. Staphylococcus aureus phenotype switching: an effective bacterial strategy to escape host immune response and establish a chronic infection. EMBO Mol Med 3:129-141. http://dx.doi.org/10.1002/emmm.201000115.
13. von Eiff C, Becker K, Metze D, Lubritz G, Hockmann J, Schwarz T, Peters G. 2001. Intracellular persistence of Staphylococcus aureus small-colony variants within keratinocytes: a cause for antibiotic treatment failure in a patient with Darier's disease. Clin Infect Dis 32:1643-1647. http://dx.doi.org/10.1086/320519.
14. von Eiff C, Peters G, Becker K. 2006. The small colony variant (SCV) concept: the role of staphylococcal SCVs in persistent infections. Injury 37:S26-S33. http://dx.doi.org/10.1016/j.injury.2006.04.006.
15. Dean MA, Olsen RJ, Long SW, Rosato AE, Musser JM. 2014. Identification of point mutations in clinical Staphylococcus aureus strains that produce small colony variants auxotrophic for menadione. Infect Immun 82:1600-1605. http://dx.doi.org/10.1128/IAI.01487-13.
16. Kriegeskorte A, Block D, Drescher M, Windmüller N, Mellmann A, Baum C, Neumann C, Lorè NI, Bragonzi A, Liebau E, Hertel P, Seggewiss J, Becker K, Proctor RA, Peters G, Kahl BC. 2014. Inactivation of thyA in Staphylococcus aureus attenuates virulence and has a strong impact on metabolism and virulence gene expression. mBio 5:e01447-14. http://dx.doi.org/10.1128/mBio.01447-14.
17. Lannergård J, von Eiff C, Sander G, Cordes T, Seggewiss J, Peters G, Proctor RA, Becker K, Hughes D. 2008. Identification of the genetic basis for clinical menadione-auxotrophic small-colony variant isolates of Staphylococcus aureus. Antimicrob Agents Chemother 52:4017-4022. http://dx.doi.org/10.1128/AAC.00668-08.
18. Schaaff F, Bierbaum G, Baumert N, Bartmann P, Sahl HG. 2003. Mutations are involved in emergence of aminoglycoside-induced small colony variants of Staphylococcus aureus. Int J Med Microbiol 293:427-435. http://dx.doi.org/10.1078/1438-4221-00282.
19. von Eiff C, Heilmann C, Proctor RA, Woltz C, Peters G, Götz F. 1997. A site-directed Staphylococcus aureus hemB mutant is a small-colony variant which persists intracellularly. J Bacteriol 179:4012-4706.
20. Gaupp R, Schlag S, Liebeke M, Lalk M, Götz F. 2010. Advantage of upregulation of succinate dehydrogenase in Staphylococcus aureus biofilms. J Bacteriol 192:2385-2394. http://dx.doi.org/10.1128/JB.01472-09.
21. Norstrom T, Lannergard J, Hughes D. 2007. Genetic and phenotypic identification of fusidic acid-resistant mutants with the small-colonyvariant phenotype in Staphylococcus aureus. Antimicrob Agents Chemother 51:4438-4446. http://dx.doi.org/10.1128/AAC.00328-07.
22. Edwards AM. 2012. Phenotype switching is a natural consequence of Staphylococcus aureus replication. J Bacteriol 194:5404-5412. http://dx.doi.org/10.1128/JB.00948-12.
23. Massey RC, Buckling A, Peacock SJ. 2001. Phenotypic switching of antibiotic resistance circumvents permanent costs in Staphylococcus aureus. Curr Biol 11:1810-1814. http://dx.doi.org/10.1016/S0960-9822(01)00507-3.
24. Vesga O, Groeschel MC, Otten MF, Brar DW, Vann JM, Proctor RA. 1996. Staphylococcus aureus small colony variants are induced by the endothelial cell intracellular milieu. J Infect Dis 173:739-742. http://dx.doi.org/10.1093/infdis/173.3.739.
25. Baumert N, von Eiff C, Schaaff F, Peters G, Proctor RA, Sahl HG. 2002. Physiology and antibiotic susceptibility of Staphylococcus aureus small colony variants. Microb Drug Resist 8:253-260. http://dx.doi.org/10.1089/10766290260469507.
26. Bates DM, von Eiff C, McNamara PJ, Peters G, Yeaman MR, Bayer AS, Proctor RA. 2003. Staphylococcus aureus menD and hemB mutants are as infective as the parent strains, but the menadione biosynthetic mutant persists within the kidney. J Infect Dis 187:1654-1661. http://dx.doi.org/10.1086/374642.
27. Brouillette E, Grondin G, Lefebvre C, Talbot BG, Malouin F. 2004. Mouse mastitis model of infection for antimicrobial compound efficacy studies against intracellular and extracellular forms of Staphylococcus aureus. Vet Microbiol 101:253-262. http://dx.doi.org/10.1016/j.vetmic.2004.04.008.
28. Garcia LG, Lemaire S, Kahl BC, Becker K, Proctor RA, Denis O, Tulkens PM, Van Bambeke F. 2013. Antibiotic activity against smallcolony variants of Staphylococcus aureus: review of in vitro, animal and clinical data. J Antimicrob Chemother 68:1455-1464. http://dx.doi.org/10.1093/jac/dkt072.
29. Tsuji BT, von Eiff C, Kelchlin PA, Forrest A, Smith PF. 2008. Attenuated vancomycin bactericidal activity against Staphylococcus aureus hemB mutants expressing the small-colony-variant phenotype. Antimicrob Agents Chemother 52:1533-1537. http://dx.doi.org/10.1128/AAC.01254-07.
30. Seggewiss J, Becker K, Kotte O, Eisenacher M, Yazdi MR, Fischer A, McNamara P, Al Laham N, Proctor R, Peters G, Heinemann M, von Eiff C. 2006. Reporter metabolite analysis of transcriptional profiles of a Staphylococcus aureus strain with normal phenotype and its isogenic hemB mutant displaying the small-colony-variant phenotype. J Bacteriol 188:7765-7777. http://dx.doi.org/10.1128/JB.00774-06.
31. Singh R, Ray P, Das A, Sharma M. 2010. Enhanced production of exopolysaccharide matrix and biofilm by a menadione-auxotrophic Staphylococcus aureus small-colony variant. J Med Microbiol 59:521-527. http://dx.doi.org/10.1099/jmm.0.017046-0.
32. Tuchscherr L, Heitmann V, Hussain M, Viemann D, Roth J, von Eiff C, Peters G, Becker K, Löffler B. 2010. Staphylococcus aureus small-colony variants are adapted phenotypes for intracellular persistence. J Infect Dis 202:1031-1040. http://dx.doi.org/10.1086/656047.
33. Moisan H, Brouillette E, Jacob CL, Langlois-Bégin P, Michaud S, Malouin F. 2006. Transcription of virulence factors in Staphylococcus aureus small-colony variants isolated from cystic fibrosis patients is influenced by SigB. J Bacteriol 188:64-76. http://dx.doi.org/10.1128/JB.188.1.64-76.2006.
34. Mitchell G, Fugère A, Pépin Gaudreau K, Brouillette E, Frost EH, Cantin AM, Malouin F. 2013. SigB is a dominant regulator of virulence in Staphylococcus aureus small-colony variants. PLoS One 8:e65018. http://dx.doi.org/10.1371/journal.pone.0065018.
35. Pader V, James EH, Painter KL, Wigneshweraraj S, Edwards AM. 2014. The agr quorum-sensing system regulates fibronectin binding but not hemolysis in the absence of a functional electron transport chain. Infect Immun 82:4337-4347. http://dx.doi.org/10.1128/IAI.02254-14.
36. Liu GY, Essex A, Buchanan JT, Datta V, Hoffman HM, Bastian JF, Fierer J, Nizet V. 2005. Staphylococcus aureus golden pigment impairs neutrophil killing and promotes virulence through its antioxidant activity. J Exp Med 202:209-215. http://dx.doi.org/10.1084/jem.20050846.
37. Liu CI, Liu GY, Song Y, Yin F, Hensler ME, Jeng WY, Nizet V, Wang AH, Oldfield E. 2008. A cholesterol biosynthesis inhibitor blocks Staphylococcus aureus virulence. Science 319:1391-1394. http://dx.doi.org/10.1126/science.1153018.
38. Clauditz A, Resch A, Wieland KP, Peschel A, Götz F. 2006. Staphyloxanthin plays a role in the fitness of Staphylococcus aureus and its ability to cope with oxidative stress. Infect Immun 74:4950-4953. http://dx.doi.org/10.1128/IAI.00204-06.
39. Clements MO, Watson SP, Foster SJ. 1999. Characterization of the major superoxide dismutase of Staphylococcus aureus and its role in starvation survival, stress resistance, and pathogenicity. J Bacteriol 181:3898-3903.
40. Cosgrove K, Coutts G, Jonsson IM, Tarkowski A, Kokai-Kun JF, Mond JJ, Foster SJ. 2007. Catalase (KatA) and alkyl hydroperoxide reductase (AhpC) have compensatory roles in peroxide stress resistance and are required for survival, persistence, and nasal colonization in Staphylococcus aureus. J Bacteriol 189:1025-1035. http://dx.doi.org/10.1128/JB.01524-06.
41. Gaupp R, Ledala N, Somerville GA. 2012. Staphylococcal response to oxidative stress. Front Cell Infect Microbiol 2:33. http://dx.doi.org/10.3389/fcimb.2012.00033.
42. Horsburgh MJ, Ingham E, Foster SJ. 2001. In Staphylococcus aureus, fur is an interactive regulator with PerR, contributes to virulence, and Is necessary for oxidative stress resistance through positive regulation of catalase and iron homeostasis. J Bacteriol 183:468-475. http://dx.doi.org/10.1128/JB.183.2.468-475.2001.
43. Karavolos MH, Horsburgh MJ, Ingham E, Foster SJ. 2003. Role and regulation of the superoxide dismutases of Staphylococcus aureus. Microbiology 149:2749-2758. http://dx.doi.org/10.1099/mic.0.26353-0.
44. Valderas MW, Hart ME. 2001. Identification and characterization of a second superoxide dismutase gene (sodM) from Staphylococcus aureus. J Bacteriol 183:3399-3407. http://dx.doi.org/10.1128/JB.183.11.3399-3407.2001.
45. Mayfield JA, Hammer ND, Kurker RC, Chen TK, Ojha S, Skaar EP, DuBois JL. 2013. The chlorite dismutase (HemQ) from Staphylococcus aureus has a redox-sensitive heme and is associated with the small colony variant phenotype. J Biol Chem 288:23488-23504. http://dx.doi.org/10.1074/jbc.M112.442335.
46. Novick RP. 1991. Genetic systems in staphylococci. Methods Enzymol 204:587-636. http://dx.doi.org/10.1016/0076-6879(91)04029-N.
47. Lee CY, Buranen SL, Ye ZH. 1991. Construction of single-copy integration vectors for Staphylococcus aureus. Gene 103:101-105. http://dx.doi.org/10.1016/0378-1119(91)90399-V.
48. Kafala B, Sasarman A. 1997. Isolation of the Staphylococcus aureus hem-CDBL gene cluster coding for early steps in heme biosynthesis. Gene 199:231-239. http://dx.doi.org/10.1016/S0378-1119(97)00372-7.
49. Charpentier E, Anton AI, Barry P, Alfonso B, Fang Y, Novick RP. 2004. Novel cassette-based shuttle vector system for gram-positive bacteria. Appl Environ Microbiol 70:6076-6085. http://dx.doi.org/10.1128/AEM.70.10.6076-6085.2004.
50. Monk IR, Shah IM, Xu M, Tan MW, Foster TJ. 2012. Transforming the untransformable: application of direct transformation to manipulate genetically Staphylococcus aureus and Staphylococcus epidermidis. mBio 3:e00277-11. http://dx.doi.org/10.1128/mBio.00277-11.
51. Sarkar S, Ma WT, Sandri GH. 1992. On fluctuation analysis: a new, simple and efficient method for computing the expected number of mutants. Genetica 85:173-179. http://dx.doi.org/10.1007/BF00120324.
52. Hall BM, Ma C, Liang KK, Singh P. 2009. Fluctuation AnaLysis CalculatOR (FALCOR): a web tool for the determination of mutation rate using Luria-Delbruck fluctuation analysis. Bioinformatics 25:1564-1565. http://dx.doi.org/10.1093/bioinformatics/btp253.
53. Wolf C, Hochgräfe F, Kusch H, Albrecht D, Hecker M, Engelmann S. 2008. Proteomic analysis of antioxidant strategies of Staphylococcus aureus: diverse responses to different oxidants. Proteomics 8:3139-3153. http://dx.doi.org/10.1002/pmic.200701062.
54. Keyer K, Imlay JA. 1996. Superoxide accelerates DNA damage by elevating free-iron levels. Proc Natl Acad Sci U S A 93:13635-13640. http://dx.doi.org/10.1073/pnas.93.24.13635.
55. Wakeman CA, Hammer ND, Stauff DL, Attia AS, Anzaldi LL, Dikalov SI, Calcutt MW, Skaar EP. 2012. Menaquinone biosynthesis potentiates haem toxicity in Staphylococcus aureus. Mol Microbiol 86:1376-1392. http://dx.doi.org/10.1111/mmi.12063.
56. Chang W, Small DA, Toghrol F, Bentley WE. 2006. Global transcriptome analysis of Staphylococcus aureus response to hydrogen peroxide. J Bacteriol 188:1648-1659. http://dx.doi.org/10.1128/JB.188.4.1648-1659.2006.
57. Al Mamun AA, Lombardo MJ, Shee C, Lisewski AM, Gonzalez C, Lin D, Nehring RB, Saint-Ruf C, Gibson JL, Frisch RL, Lichtarge O, Hastings PJ, Rosenberg SM. 2012. Identity and function of a large gene network underlying mutagenic repair of DNA breaks. Science 338:1344-1348. http://dx.doi.org/10.1126/science.1226683.
58. Galhardo RS, Hastings PJ, Rosenberg SM. 2007. Mutation as a stress response and the regulation of evolvability. Crit Rev Biochem Mol Biol 42:399-435. http://dx.doi.org/10.1080/10409230701648502.
59. McKenzie GJ, Harris RS, Lee PL, Rosenberg SM. 2000. The SOS response regulates adaptive mutation. Proc Natl Acad Sci U S A 97:6646-6651. http://dx.doi.org/10.1073/pnas.120161797.
60. Shee C, Gibson JL, Rosenberg SM. 2012. Two mechanisms produce mutation hot spots at DNA breaks in Escherichia coli. Cell Rep 2:714-721. http://dx.doi.org/10.1016/j.celrep.2012.08.033.
61. Fey PD, Endres JL, Yajjala VK, Widhelm TJ, Boissy RJ, Bose JL, Bayles KW. 2013. A genetic resource for rapid and comprehensive phenotype screening of nonessential Staphylococcus aureus genes. mBio 4:e00537-12. http://dx.doi.org/10.1128/mBio.00537-12.
62. Cirz RT, Jones MB, Gingles NA, Minogue TD, Jarrahi B, Peterson SN, Romesberg FE. 2007. Complete and SOS-mediated response of Staphylococcus aureus to the antibiotic ciprofloxacin. J Bacteriol 189:531-539. http://dx.doi.org/10.1128/JB.01464-06.
63. Lombardo MJ, Aponyi I, Rosenberg SM. 2004. General stress response regulator RpoS in adaptive mutation and amplification in Escherichia coli. Genetics 166:669-680. http://dx.doi.org/10.1534/genetics.166.2.669.
64. Mitchell G, Séguin DL, Asselin AE, Déziel E, Cantin AM, Frost EH, Michaud S, Malouin F. 2010. Staphylococcus aureus sigma B-dependent emergence of small-colony variants and biofilm production following exposure to Pseudomonas aeruginosa 4-hydroxy-2-heptylquinoline-N-oxide. BMC Microbiol 10:33. http://dx.doi.org/10.1186/1471-2180-10-33.
65. Mitchell G, Brouillette E, Séguin DL, Asselin AE, Jacob CL, Malouin F. 2010. A role for sigma factor B in the emergence of Staphylococcus aureus small-colony variants and elevated biofilm production resulting from an exposure to aminoglycosides. Microb Pathog 48:18-27. http://dx.doi.org/10.1016/j.micpath.2009.10.003.
66. Horsburgh MJ, Aish JL, White IJ, Shaw L, Lithgow JK, Foster SJ. 2002. sigmaB modulates virulence determinant expression and stress resistance: characterization of a functional rsbU strain derived from Staphylococcus aureus 8325-4. J Bacteriol 184:5457-5467. http://dx.doi.org/10.1128/JB.184.19.5457-5467.2002.
67. Uziel O, Borovok I, Schreiber R, Cohen G, Aharonowitz Y. 2004. Transcriptional regulation of the Staphylococcus aureus thioredoxin and thioredoxin reductase genes in response to oxygen and disulfide stress. J Bacteriol 186:326-334. http://dx.doi.org/10.1128/JB.186.2.326-334.2004.
68. Hoffman LR, Déziel E, D'Argenio DA, Lépine F, Emerson J, McNamara S, Gibson RL, Ramsey BW, Miller SI. 2006. Selection for Staphylococcus aureus small-colony variants due to growth in the presence of Pseudomonas aeruginosa. Proc Natl Acad Sci U S A 103:19890-19895. http://dx.doi.org/10.1073/pnas.0606756104.
69. Chen CJ, Su LH, Lin TY, Huang YC. 2010. Molecular analysis of repeated methicillin-resistant Staphylococcus aureus infections in children. PLoS One 5:e14431. http://dx.doi.org/10.1371/journal.pone.0014431.
70. Peyrani P, Allen M, Seligson D, Roberts C, Chen A, Haque N, Zervos M, Wiemken T, Harting J, Christensen D, Ramirez R. 2012. Clinical outcomes of osteomyelitis patients infected with methicillin-resistant Staphylococcus aureus U S A-300 strains. Am J Orthop 41:117-122.
71. Rosenberg SM, Shee C, Frisch RL, Hastings PJ. 2012. Stress-induced mutation via DNA breaks in Escherichia coli: a molecular mechanism with implications for evolution and medicine. Bioessays 34:885-892. http://dx.doi.org/10.1002/bies.201200050.
72. Sale JE, Lehmann AR, Woodgate R. 2012. Y-family DNA polymerases and their role in tolerance of cellular DNA damage. Nat Rev Mol Cell Biol 13:141-152. http://dx.doi.org/10.1038/nrm3289.
73. Anderson KL, Roberts C, Disz T, Vonstein V, Hwang K, Overbeek R, Olson PD, Projan SJ, Dunman PM. 2006. Characterization of the Staphylococcus aureus heat shock, cold shock, stringent, and SOS responses and their effects on log-phase mRNA turnover. J Bacteriol 188:6739-6756. http://dx.doi.org/10.1128/JB.00609-06.
74. Kriegeskorte A, König S, Sander G, Pirkl A, Mahabir E, Proctor RA, von Eiff C, Peters G, Becker K. 2011. Small colony variants of Staphylococcus aureus reveal distinct protein profiles. Proteomics 11:2476-2490. http://dx.doi.org/10.1002/pmic.201000796.
75. Balaban NQ. 2011. Persistence: mechanisms for triggering and enhancing phenotypic variability. Curr Opin Genet Dev 21:768-775. http://dx.doi.org/10.1016/j.gde.2011.10.001.
76. Lewis K. 2012. Persister cells: molecular mechanisms related to antibiotic tolerance. Handb Exp Pharmacol 211:121-133. http://dx.doi.org/10.1007/978-3-642-28951-4_8.
77. Balaban NQ, Merrin J, Chait R, Kowalik L, Leibler S. 2004. Bacterial persistence as a phenotypic switch. Science 305:1622-1625. http://dx.doi.org/10.1126/science.1099390.
78. Johnson PJ, Levin BR. 2013. Pharmacodynamics, population dynamics, and the evolution of persistence in Staphylococcus aureus. PLoS Genet 9:e1003123. http://dx.doi.org/10.1371/journal.pgen.1003123.
79. Kussell E, Kishony R, Balaban NQ, Leibler S. 2005. Bacterial persistence: a model of survival in changing environments. Genetics 169:1807-1814. http://dx.doi.org/10.1534/genetics.104.035352.
80. Woodmansee AN, Imlay JA. 2002. Reduced flavins promote oxidative DNA damage in non-respiring Escherichia coli by delivering electrons to intracellular free iron. J Biol Chem 277:34055-34066. http://dx.doi.org/10.1074/jbc.M203977200.
81. + redox poise in Streptomyces coelicolor A3(2). EMBO J 22:4856-4865. http://dx.doi.org/10.1093/emboj/cdg453.
82. Hecker M, Reder A, Fuchs S, Pagels M, Engelmann S. 2009. Physiological proteomics and stress/starvation responses in Bacillus subtilis and Staphylococcus aureus. Res Microbiol 160:245-258. http://dx.doi.org/10.1016/j.resmic.2009.03.008.
83. Richardson AR, Libby SJ, Fang FC. 2008. A nitric oxide-inducible lactate dehydrogenase enables Staphylococcus aureus to resist innate immunity. Science 319:1672-1676. http://dx.doi.org/10.1126/science.1155207.
84. Chittezham TV, Kinkead LC, Janssen A, Schaeffer CR, Woods KM, Lindgren JK, Peaster JM, Chaudhari SS, Sadykov M, Jones J, Abdel-Ghani SM, Zimmerman MC, Bayles KW, Somerville GA, Fey PD. 2013. A dysfunctional tricarboxylic acid cycle enhances fitness of Staphylococcus epidermidis during -lactam stress. mBio 4:e00437-13. http://dx.doi.org/10.1128/mBio.00437-13.
85. Diep BA, Gill SR, Chang RF, Phan TH, Chen JH, Davidson MG, Lin F, Lin J, Carleton HA, Mongodin EF, Sensabaugh GF, Perdreau-Remington F. 2006. Complete genome sequence of USA300, an epidemic clone of community-acquired methicillin-resistant Staphylococcus aureus. Lancet 367:731-739. http://dx.doi.org/10.1016/S0140-6736(06)68231-7.
86. Holden MT, Feil EJ, Lindsay JA, Peacock SJ, Day NP, Enright MC, Foster TJ, Moore CE, Hurst L, Atkin R, Barron A, Bason N, Bentley SD, Chillingworth C, Chillingworth T, Churcher C, Clark L, Corton C, Cronin A, Doggett J, Dowd L, Feltwell T, Hance Z, Harris B, Hauser H, Holroyd S, Jagels K, James KD, Lennard N, Line A, Mayes R, Moule S, Mungall K, Ormond D, Quail MA, Rabbinowitsch E, Rutherford K, Sanders M, Sharp S, Simmonds M, Stevens K, Whitehead S, Barrell BG, Spratt BG, Parkhill J. 2004. Complete genomes of two clinical Staphylococcus aureus strains: evidence for the rapid evolution of virulence and drug resistance. Proc Natl Acad Sci U S A 101:9786-9791. http://dx.doi.org/10.1073/pnas.0402521101.